Heparins are widely used for the prophylaxis/treatment of thromboembolic events. As adverse effects, heparin‐induced skin lesions occur frequently (in 7.5–39% of patients). Skin lesions may be the only clinical manifestation… Click to show full abstract
Heparins are widely used for the prophylaxis/treatment of thromboembolic events. As adverse effects, heparin‐induced skin lesions occur frequently (in 7.5–39% of patients). Skin lesions may be the only clinical manifestation of life‐threatening immune‐mediated heparin‐induced thrombocytopenia, but are commonly caused by a delayed‐type hypersensitivity response [heparin‐induced delayed‐type hypersensitivity (HIHS)]. Risk factors have not been prospectively identified.
               
Click one of the above tabs to view related content.